Patients who completed titration and , during the last @ days of titration , had mean pain intensity < @ ( based on twice-daily ratings ) and mean rescue medication use = @ mg/day continued into a @-week maintenance period ; patients who received morphine CR during titration continued taking morphine CR , and those who received tapentadol PR were re-randomized ( @:@ ) to tapentadol PR or placebo bid .